Author:
James Chelsi,Whitehead Akeem,Plummer Jasmine T.,Thompson Rory,Badal Simone
Publisher
Springer Science and Business Media LLC
Reference161 articles.
1. Society, T.A.C. (2014). Understanding what cancer is: Ancient times to present. https://www.cancer.org/cancer/understanding-cancer/history-of-cancer/what-is-cancer.html.
2. Miller, K.D., Nogueira, L., Devasi, T., Mariotto, A.B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R.L. (2022). Cancer treatment and survivorship statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 409–436.
3. Gonzalez-Nicolini, V., & Fussenegger, M. (2005). In vitro assays for anticancer drug discovery—A novel approach based on engineered mammalian cell lines. Anti-Cancer Drugs, 16, 223–228.
4. Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993). Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines. British Journal of Cancer, 68, 1104–1109.
5. Merlin, J.-L., Barberi-Heyob, M., & Bachmann, N. (2002). In vitro comparative evaluation of trastuzumab (Herceptin®) combined with paclitaxel (Taxol®) or docetaxel (Taxotere®) in HER2-expressing human breast cancer cell lines. Annals of Oncology, 13, 1743–1748.